Variability in How Cancer Cells Respond to Drugs Investigated

News   Oct 30, 2017 | Original story by Kevin Jiang for Harvard Medical School

 
Variability in How Cancer Cells Respond to Drugs Investigated
 
 
 

RELATED ARTICLES

Existing 20-year-old Multiple Sclerosis Drug Effective Against Multi-resistant Bacteria

News

A widely-used and twenty-year-old medicine used to treat multiple sclerosis can also beat a type of multi-resistant bacteria for which there are currently only a few effective drugs.

READ MORE

Novel Chemistry Technique Simplifies Late-Stage Modification of Drug Compounds

News

Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.

READ MORE

Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line Treatment

News

The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE